로봇 신경외과 시장 - 세계 및 지역별 분석 : 용도별, 제품 유형별, 최종사용자별, 지역별 - 분석과 예측(2025-2035년)

This report can be delivered within 1 working day.

Introduction to Robotic Neurosurgery Market

The global robotic neurosurgery market is projected to reach $2,238.6 million in 2035 and estimated $334.8 million in 2023, growing at a CAGR of 16.35% during the forecast period 2025-2035. Key factors driving this growth include the rising prevalence of neurological disorders, which increases the demand for advanced surgical interventions. Technological innovations, including improved precision, the integration of real-time imaging, and AI-enabled capabilities, are enhancing surgical outcomes and broadening the scope of robotic neurosurgery.

Additionally, the shift toward minimally invasive procedures has been fueling adoption by reducing patient recovery times and complication rates. The expansion of healthcare infrastructure worldwide, particularly in emerging markets, further supports market growth. Moreover, increased investment in research and development, coupled with strategic collaborations among industry players, has been accelerating product innovation and market penetration, solidifying robotic neurosurgery's role as a key growth sector in the healthcare industry.

Market Introduction

The global robotic neurosurgery market is categorized into key segments based on product type and clinical application to provide a clear framework for analysis and growth opportunities. Product types include robotic systems, the core platforms that enable precise and minimally invasive surgeries, alongside essential services such as installation, training, maintenance, and software updates that ensure optimal system functionality. Additionally, instruments and accessories, comprising specialized surgical tools and consumables, play a critical role in procedure success and ongoing demand. On the application side, the market is primarily divided into spinal neurosurgery, which addresses conditions related to the spine, and cranial neurosurgery, focused on brain and skull-related procedures. Geographically, the market has been expanding across regions including North America, Europe, Asia-Pacific, and the Rest-of-the-World. This segmentation enables industry stakeholders to identify trends, allocate resources effectively, and tailor innovations to meet the specific needs of different surgical domains, thereby capitalizing on regional growth.

Impact Analysis:

The robotic neurosurgery market has made an impact in the following ways:

• Enhanced Surgical Precision: Robotic systems have significantly improved the accuracy of complex neurosurgical procedures, thereby reducing risks and enhancing patient outcomes.
• Minimally Invasive Techniques: The adoption of robotics has enabled less invasive surgeries, leading to shorter recovery times, reduced complications, and lower healthcare costs.
• Expanded Access to Advanced Care: Robotics has facilitated the availability of cutting-edge neurosurgical interventions in more healthcare facilities worldwide, including underserved regions.
• Innovation and Market Growth: Continuous technological advancements and increased investments have accelerated the development of new robotic platforms and instruments, driving robust market expansion.

Market Segmentation:

Segmentation 1: by Product Type

• Robotic Systems
• Services
• Instruments and Accessories

Instruments and Accessories Segment to Continue Dominating the Robotic Neurosurgery Market (by Product Type)

Based on product type, the robotic neurosurgery market is led by instrument and accessories, which held a 51.48% share in 2023.

Segmentation 2: by Application

• Spinal Neurosurgery
• Cranial Neurosurgery

Spinal Neurosurgery Segment to Continue Dominating the Robotic Neurosurgery Market (by Application)

Based on application, the robotic neurosurgery market is led by spinal neurosurgery, which held a 73.51% share in 2023.

Segmentation 3: by End User

• Hospitals
• Ambulatory Surgical Centers

Hospitals Segment to Continue Holding its Dominance in the Robotic Neurosurgery Market (by End User)

Based on end users, the robotic neurosurgery market is led by hospitals, which held a 91.90% share in 2023.

Segmentation 4: by Region

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest-of-Asia-Pacific
• Rest-of-the-World

China dominated the Asia-Pacific robotic neurosurgery market in 2023, driven by several key factors. These include rapid advancements in healthcare infrastructure, strong government support for the adoption of medical technology, and a large patient population with a rising prevalence of neurological disorders. Additionally, increasing investments in research and development, coupled with growing awareness and acceptance of minimally invasive surgical techniques, have fueled demand for robotic neurosurgery systems. The presence of leading domestic manufacturers and strategic partnerships with global technology providers further strengthen China's leadership position in the regional market.

Recent Developments in the Robotic Neurosurgery Market

• In April 2025, Brain Navi Biotechnology Co., Ltd. announced the commencement of its initial public offering (IPO) counseling with First Securities Inc., a significant move toward tapping into the capital markets to fuel its long-term growth in the surgical robot technology sector.
• In March 2025, Brain Navi Biotechnology, a pioneer in neurosurgical robotics, revealed a strategic partnership with BenQ Medical Technology to launch and commercialize the NaoTrac neurosurgical navigation robot in China. This collaboration supports Brain Navi's 2025 globalization strategy, focusing on localized partnerships to expedite market entry and boost clinical adoption.
• In August 2024, MMI (Medical Microinstruments, Inc.) announced the successful completion of a preclinical study that confirmed the feasibility of the Symani Surgical System for neurosurgical procedures.
• In May 2024, AiM Medical Robotics Inc. announced a collaboration with Brigham and Women's Hospital (BWH) and the Surgical Navigation and Robotics (SNR) Lab at Harvard to validate their advanced robot for deep brain stimulation in Parkinson's patients.
• In May 2024, Monteris Medical Corporation announced the release of the NeuroBlate NB3 FullFire 1.6mm laser probe, designed for use with their robotic-assisted NeuroBlate system.

Demand - Drivers and Limitations

Market Demand Drivers:

• Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures: Robotic-assisted neurosurgical procedures offer significant advantages over conventional open surgeries, making them a game-changer in modern medicine. Analysts view these systems as a major advancement due to their enhanced precision and accuracy, which allows for more accurate targeting of critical brain and spinal areas, reducing the risk of damaging healthy tissues. The minimally invasive nature of robotic surgeries results in smaller incisions, reduced blood loss, faster recovery times, and shorter hospital stays, ultimately improving patient outcomes and lowering healthcare costs.

Additionally, robotic systems reduce the likelihood of complications such as brain swelling, bleeding, and infections, which are common in traditional open surgeries. Surgeons also benefit from improved efficiency, greater control, and enhanced comfort, as robotic platforms offer superior dexterity and 3D visualization. With these advantages, the growing demand for robotic neurosurgery has been reshaping the field, offering patients safer, more effective treatments while driving cost savings for healthcare providers. As technology continues to evolve, analysts predict that robotic neurosurgery will become the standard of care for a wide range of neurological procedures.

• Rising Prevalence of Neurological Disorders: The rising incidence of neurological conditions has been significantly influencing the expansion of the robotic neurosurgery market. As the demand for advanced, minimally invasive surgical options continues to grow, robotic systems are poised to play a crucial role in modern neurosurgical practices, thereby enhancing patient care and surgical efficiency. The study published in The Lancet Neurology reveals that neurological conditions have become the leading cause of ill health and disability globally, affecting approximately 3.4 million people in 2021. This marks a significant increase over the past three decades, with the number of disability-adjusted life years (DALYs) rising by 18% from 1990 to 2021. The primary contributors to this burden include stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, and diabetic neuropathy. Notably, neurodevelopmental and pediatric conditions accounted for nearly 20% of the total neurological burden worldwide, equating to 80 million years of healthy life lost in 2021.

The rise in neurological disorders is attributed to factors such as population aging, increased life expectancy, and exposure to environmental, metabolic, and lifestyle risk factors. Alarmingly, over 80% of neurological deaths and health loss occur in low- and middle-income countries, underscoring significant health disparities. The study highlights the importance of implementing effective prevention, treatment, rehabilitation, and long-term care strategies to address this growing public health issue.

This escalating prevalence of neurological conditions is a key driver for the robotic neurosurgery market. The increasing demand for effective and minimally invasive treatment options has spurred the adoption of robotic-assisted neurosurgical procedures. These technologies offer enhanced precision, reduced complications, and shorter recovery times compared to traditional open surgeries, positioning them as a critical component in modern neurosurgical practices.

Market Restraints:

• High Cost of Investment: The high cost of acquiring neurosurgery robots presents a significant financial hurdle for many healthcare institutions, hindering the widespread adoption of this transformative technology. The initial investment required for robotic systems, along with ongoing maintenance, training, and operational costs, can create a considerable budgetary challenge, particularly for smaller hospitals or those with limited financial resources. As hospitals look to integrate robotic systems, they must carefully assess the total cost of ownership, factoring in not only the upfront purchase price but also the long-term operational expenses.

Market Opportunities:

• Development of Long-Distance Teleoperated Surgical Robotic Systems: The development of long-distance teleoperated surgical robotic systems presents a significant opportunity for the robotic neurosurgery market. By enabling remote access to specialized neurosurgical care, these systems can overcome geographical barriers, improving healthcare access in underserved and rural regions. The integration of advanced robotics, real-time communication, and artificial intelligence enhances surgical precision, reduces recovery times, and offers cost-effective solutions for hospitals. Moreover, the ability to provide remote training and collaboration among surgeons worldwide fosters continuous innovation and knowledge sharing, further accelerating the adoption of robotic systems. As technology continues to evolve, the potential for long-distance robotic neurosurgery will expand, driving market growth and reshaping the future of surgical care globally.

How can this report add value to an organization?

Product/Innovation Strategy: The global robotic neurosurgery market has been extensively segmented based on various categories, such as product type, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: The new offering accounted for the maximum number of key developments in the global robotic neurosurgery market between January 2022 and April 2025.

Competitive Strategy: The global robotic neurosurgery market has numerous established players with product and service portfolios. Key players in the global robotic neurosurgery market, as analyzed and profiled in the study, include established companies offering robotic neurosurgery systems, instruments, accessories, and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
• Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the offering, application, end user, and region were then estimated for each market player based on fact-based proxy indicators, as well as primary inputs.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of robotic neurosurgery.
• The market contribution of robotic neurosurgery, anticipated to be launched in the future, has been calculated based on historical analysis. This analysis has been supported by proxy factors, including the innovation scale of the companies, funding status, collaborations, customer base, and patent scenario.
• The scope of availability of robotic neurosurgery products and services in a particular region has been assessed through a comprehensive analysis of companies' prospects, regional end-user perceptions, and other factors influencing the launch of robotic neurosurgery products and services in that region.
• The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period from FY2025 to FY2035.
• Revenues of the companies have been referenced from their annual reports for FY2021-FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
• The regional distribution of market revenue has been estimated based on the number of companies in each region and the adoption rate of robotic neurosurgery. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
• The market has been mapped based on the available robotic neurosurgery. All the key companies with significant offerings in this field have been considered and profiled in this report.
• Market strategies and developments of key players have been taken into account for calculating the market potential in the forecast period.

Primary Research:

The primary sources involve industry experts in the robotic neurosurgery market, including the market players offering robotic neurosurgery solutions. Resources, including CXOs, vice presidents, product managers, directors, territory managers, and business development professionals, have been interviewed to gather and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings for robotic neurosurgery
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolios
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentation and percentage share estimates
• Company and country understanding and data for market value estimation
• Key industry/market trends
• Developments among top players
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global robotic neurosurgery market include:

• Brainlab AG
• Renishaw plc
• Zimmer Biomet Holding, Inc.
• Medical Microinstruments, Inc.
• Monteris Medical Corporation
• Medtronic plc.
• Globus Medical Inc.
• Accuray Incorporated

Table of Contents

Executive Summary

Scope and Definition

1 Global Robotic Neurosurgery Market: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
  • 1.1.2 Significant Number of Collaborations among Market Players
  • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
• 1.2 Supply Chain Overview
• 1.3 Regulatory Framework
  • 1.3.1 U.S.
  • 1.3.2 European Union (EU)
  • 1.3.3 U.K.
  • 1.3.4 Japan
  • 1.3.5 China
  • 1.3.6 Rest-of-the-World (RoW)
• 1.4 Reimbursement Scenario
  • 1.4.1 Reimbursement Scenario in the U.S.
• 1.5 Patent Analysis
  • 1.5.1 Patent Filing Trend (by Country, Year)
• 1.6 Pricing Analysis
• 1.7 Case Studies
  • 1.7.1 Case Study: First Use of Mazor X Stealth Edition Robotic Guidance Platform at an Outpatient Surgery Center in Ohio
  • 1.7.2 Case Study: Brain Navi's NaoTrac Reaches 100 Neurosurgical Procedures Milestone
• 1.8 Funding Scenario
• 1.9 Market Dynamics
  • 1.9.1 Market Drivers
    • 1.9.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
    • 1.9.1.2 Rising Prevalence of Neurological Disorders
    • 1.9.1.3 Continuous Technological Advancements in Robotic Neurosurgery
  • 1.9.2 Market Restraints
    • 1.9.2.1 High Cost of Investment
    • 1.9.2.2 Lack of Skilled Professionals
  • 1.9.3 Market Opportunities
    • 1.9.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Global Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035

• 2.1 Robotic Systems
• 2.2 Instruments and Accessories
• 2.3 Services

3 Global Robotic Neurosurgery Market (by Application), $Million, 2023-2035

• 3.1 Spinal Neurosurgery
• 3.2 Cranial Neurosurgery

4 Global Robotic Neurosurgery Market (by End User), $Million, 2023-2035

• 4.1 Hospitals
• 4.2 Ambulatory Surgical Centers

5 Global Robotic Neurosurgery Market (by Region), $Million, 2023-2035

• 5.1 Regional Summary
• 5.2 North America
  • 5.2.1 Regional Overview
  • 5.2.2 Driving Factors for Market Growth
  • 5.2.3 Factors Challenging the Market
  • 5.2.4 Procedure Volume
  • 5.2.5 U.S.
  • 5.2.6 Canada
• 5.3 Europe
  • 5.3.1 Regional Overview
  • 5.3.2 Driving Factors for Market Growth
  • 5.3.3 Factors Challenging the Market
  • 5.3.4 Procedure Volume
  • 5.3.5 Germany
  • 5.3.6 Spain
  • 5.3.7 U.K.
  • 5.3.8 Rest-of-Europe
• 5.4 Asia-Pacific
  • 5.4.1 Regional Overview
  • 5.4.2 Driving Factors for Market Growth
  • 5.4.3 Factors Challenging the Market
  • 5.4.4 Procedure Volume
  • 5.4.5 China
  • 5.4.6 Japan
  • 5.4.7 India
  • 5.4.8 Australia
  • 5.4.9 South Korea
  • 5.4.10 Rest-of-Asia-Pacific
• 5.5 Rest-of-the-World
  • 5.5.1 Regional Overview
  • 5.5.2 Driving Factors for Market Growth
  • 5.5.3 Factors Challenging the Market
  • 5.5.4 Procedure Volume

6 Markets - Product Profiles

• 6.1 Medtronic plc
  • 6.1.1 Product Overview
  • 6.1.2 Launch Year
  • 6.1.3 Key Features
  • 6.1.4 Key Parameter
  • 6.1.5 Installed Base
  • 6.1.6 Unit Sold
• 6.2 Globus Medical, Inc.
  • 6.2.1 Product Overview
  • 6.2.2 Launch Year
  • 6.2.3 Key Features
  • 6.2.4 Key Parameter
  • 6.2.5 Installed Base
  • 6.2.6 Unit Sold
• 6.3 Renishaw plc
  • 6.3.1 Product Overview
  • 6.3.2 Launch Year
  • 6.3.3 Key Features
  • 6.3.4 Key Parameter
  • 6.3.5 Installed Base
  • 6.3.6 Unit Sold
• 6.4 Zimmer Biomet Holdings, Inc.
  • 6.4.1 Product Overview
  • 6.4.2 Launch Year
  • 6.4.3 Key Features
  • 6.4.4 Key Parameter
  • 6.4.5 Installed Base
  • 6.4.6 Unit Sold

7 Markets - Competitive Benchmarking & Company Profiles

• 7.1 Product Benchmarking
• 7.2 Key Strategies and Development
• 7.3 Company Profiles
  • 7.3.1 Brainlab AG
    • 7.3.1.1 Overview
    • 7.3.1.2 Top Products/Product Portfolio
    • 7.3.1.3 Top Competitors
    • 7.3.1.4 Target Customers
    • 7.3.1.5 Key Personal
    • 7.3.1.6 Analyst View
  • 7.3.2 Renishaw plc
    • 7.3.2.1 Overview
    • 7.3.2.2 Top Products/Product Portfolio
    • 7.3.2.3 Top Competitors
    • 7.3.2.4 Target Customers
    • 7.3.2.5 Key Personal
    • 7.3.2.6 Analyst View
  • 7.3.3 Globus Medical, Inc.
    • 7.3.3.1 Overview
    • 7.3.3.2 Top Products/Product Portfolio
    • 7.3.3.3 Top Competitors
    • 7.3.3.4 Target Customers
    • 7.3.3.5 Key Personal
    • 7.3.3.6 Analyst View
  • 7.3.4 Zimmer Biomet Holdings, Inc.
    • 7.3.4.1 Overview
    • 7.3.4.2 Top Products/Product Portfolio
    • 7.3.4.3 Top Competitors
    • 7.3.4.4 Target Customers
    • 7.3.4.5 Key Personal
    • 7.3.4.6 Analyst View
  • 7.3.5 Medical Microinstruments, Inc.
    • 7.3.5.1 Overview
    • 7.3.5.2 Top Products/Product Portfolio
    • 7.3.5.3 Top Competitors
    • 7.3.5.4 Target Customers
    • 7.3.5.5 Key Personal
    • 7.3.5.6 Analyst View
  • 7.3.6 Monteris Medical Corporation
    • 7.3.6.1 Overview
    • 7.3.6.2 Top Products/Product Portfolio
    • 7.3.6.3 Top Competitors
    • 7.3.6.4 Target Customers
    • 7.3.6.5 Key Personal
    • 7.3.6.6 Analyst View
  • 7.3.7 Medtronic plc
    • 7.3.7.1 Overview
    • 7.3.7.2 Top Products/Product Portfolio
    • 7.3.7.3 Top Competitors
    • 7.3.7.4 Target Customers
    • 7.3.7.5 Key Personal
    • 7.3.7.6 Analyst View
  • 7.3.8 Accuray Incorporated
    • 7.3.8.1 Overview
    • 7.3.8.2 Top Products/Product Portfolio
    • 7.3.8.3 Top Competitors
    • 7.3.8.4 Target Customers
    • 7.3.8.5 Key Personal
    • 7.3.8.6 Analyst View
  • 7.3.9 AiM Medical Robotics
    • 7.3.9.1 Overview
    • 7.3.9.2 Top Products/Product Portfolio
    • 7.3.9.3 Top Competitors
    • 7.3.9.4 Target Customers
    • 7.3.9.5 Key Personal
    • 7.3.9.6 Analyst View
  • 7.3.10 KUKA AG (Midea Group)
    • 7.3.10.1 Overview
    • 7.3.10.2 Top Products/Product Portfolio
    • 7.3.10.3 Top Competitors
    • 7.3.10.4 Target Customers
    • 7.3.10.5 Key Personal
    • 7.3.10.6 Analyst View
  • 7.3.11 Beijing Baihui Weikang Technology Co., Ltd.
    • 7.3.11.1 Overview
    • 7.3.11.2 Top Products/Product Portfolio
    • 7.3.11.3 Top Competitors
    • 7.3.11.4 Target Customers
    • 7.3.11.5 Key Personal
    • 7.3.11.6 Analyst View
  • 7.3.12 Brain Navi Biotechnology Co. Ltd
    • 7.3.12.1 Overview
    • 7.3.12.2 Top Products/Product Portfolio
    • 7.3.12.3 Top Competitors
    • 7.3.12.4 Target Customers
    • 7.3.12.5 Key Personal
    • 7.3.12.6 Analyst View
  • 7.3.13 Beijing Tinavi Medical Technologies Co., Ltd.
    • 7.3.13.1 Overview
    • 7.3.13.2 Top Products/Product Portfolio
    • 7.3.13.3 Top Competitors
    • 7.3.13.4 Target Customers
    • 7.3.13.5 Key Personal
    • 7.3.13.6 Analyst View

8 Research Methodology

• 8.1 Data Sources
  • 8.1.1 Primary Data Sources
  • 8.1.2 Secondary Data Sources
  • 8.1.3 Data Triangulation
• 8.2 Market Estimation and Forecast